Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858
Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858
Price:
17.65
CNY
0.74%
Market Closed
Market Cap:
¥18.6B
Relative Value
The Relative Value of one
Shandong Buchang Pharmaceuticals Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 17.65 CNY,
Shandong Buchang Pharmaceuticals Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shandong Buchang Pharmaceuticals Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Shandong Buchang Pharmaceuticals Co Ltd Competitors
Shandong Buchang Pharmaceuticals Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858
|
18.6B CNY | 1.7 | 11 195.2 | 65.5 | 65.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.2B USD | 16.3 | 52.5 | 35.3 | 37.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571.3B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.8B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226.6B CHF | 5.2 | 20.3 | 12.8 | 16.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.9B GBP | 5.2 | 31.9 | 15.2 | 22.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4 | 12.3 | 8.6 | 10 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.4 | 19.7 | 7.4 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.8B USD | 2.5 | 19.6 | 7 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
